CapForce (OPGN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Oct, 2026Executive summary
Annual meeting scheduled for Dec. 9, 2026, at 8:00 a.m. ET, exclusively by online audio broadcast; stockholders can vote online before or during the meeting.
Proposals: elect six directors for one-year terms and ratify Beckles & Co., Inc. as independent auditor for FY2026; the Board recommends FOR both.
Voting matters and shareholder proposals
Director nominees are Victor Chua Kok Hoe, John Tan Honjian, Ken Lim Zhao Qi, Ethan Low Yu Jie, Constance Wong Poh Yin, and Mohd Azham Azudin; election is by plurality.
Auditor ratification requires a majority of votes cast; if not ratified, the Audit Committee may reconsider its selection.
Proposals and director recommendations for the 2027 annual meeting are due July 2–Aug. 1, 2027, subject to an alternate deadline if the meeting date shifts by more than 30 days.
Board of directors and corporate governance
The Board has six members; Messrs. Chua and Lim are deemed independent, while controlled-company status permits reliance on Nasdaq exemptions from certain independence requirements.
No formal Board or committee meetings were held during FY2025; the Board conducts director nominations and corporate governance responsibilities without a dedicated nominating committee.
In Oct. 2026, John Tan Honjian became CEO, Christian-Laurent Bonte moved to President, Business Development, and Mohd Azham Azudin joined the Board as Tan Theng Wei became COO.
Latest events from CapForce
- Q2 2026 revenue soared to $50M, with $42.5M net income from a single major client contract.OPGN
Q2 2026 - Net loss increased to $0.7 million in Q1 2026, with no revenue and continued reliance on external financing.OPGN
Q1 2026 - 2025 revenue jumped to $30.2M, net income reached $23.6M, led by fintech and advisory growth.OPGN
Q4 2025 - All seven proposals, including director elections and a name change, were approved by majority vote.OPGN
AGM 2026 - Shareholders will vote on seven key proposals, including a new equity plan and company name change.OPGN
Proxy Filing - Shareholders will vote on key governance, compensation, and structural changes, including a name change.OPGN
Proxy Filing - Q2 2025 revenue reached $4.0M from listing sponsorship, with net income of $3.5M.OPGN
Q2 2025 - OpGen posted $8.9M Q3 net income, exited diagnostics, and secured $9M equity funding for fintech pivot.OPGN
Q4 2023 - OpGen's revenue collapsed and liquidity remains critical as it pursues a sale or strategic transaction.OPGN
Q2 2024